UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Cox Capital Mgt LLC

Cox Capital Mgt LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 46.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,559 shares of the healthcare conglomerate's stock after selling 3,983 shares during the period. UnitedHealth Group comprises about 1.7% of Cox Capital Mgt LLC's portfolio, making the stock its 24th largest position. Cox Capital Mgt LLC's holdings in UnitedHealth Group were worth $2,388,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of UNH. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group during the fourth quarter valued at about $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group in the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at approximately $32,000. Institutional investors own 87.86% of the company's stock.

Insiders Place Their Bets

In other news, Director John H. Noseworthy bought 300 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the purchase, the director now directly owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 in the last 90 days. 0.33% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Wolfe Research reduced their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. HSBC reissued a "reduce" rating and issued a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Mizuho decreased their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Finally, KeyCorp cut their target price on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $428.43.

UnitedHealth Group Price Performance

NYSE:UNH traded down $3.29 during trading hours on Tuesday, reaching $301.43. 12,750,928 shares of the company were exchanged, compared to its average volume of 6,861,254. The stock's 50-day moving average is $426.60 and its 200-day moving average is $490.74. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The firm has a market cap of $273.44 billion, a PE ratio of 19.45, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the firm posted $6.91 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.